Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 15/04/20021 min de leitura
Implantation or Injectable Dosage Form New Animal Drugs; Sometribove Zinc Suspension
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Monsanto Co. which provides for subcutaneous injection of sometribove zinc suspension in healthy lactating dairy cows to increase the production of marketable milk with no restriction on injection site. Three injection sites are recommended.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →